Succinylcholine Chloride Injection, Solution
FDA Label NDC 0143-9338

36 label sections · Submitted to the FDA by Hikma Pharmaceuticals Usa Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hikma Pharmaceuticals Usa Inc. for the product Succinylcholine Chloride (NDC 0143-9338). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: ventricular dysrhythmias, cardiac arrest, and death from hyperkalemic rhabdomyolysis in pediatric patients, 1 indications and usage, 2.1 important dosage and administration information, 2.3 dosage recommendations for intravenous use in pediatric patients, 2.4 dosage recommendations for intramuscular use in adults and pediatric patients, 2.5 preparation of succinylcholine chloride injection, 2.6 drug incompatibility, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.